Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment

Clicks: 389
ID: 267162
2005
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #93 of 552 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 552 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Effective methods to diminish the burden of hepatitis C virus (HCV) infection among injection drug users (IDUs) require consideration of the epidemiology and natural history of both hepatitis C and drug use. Most HCV infections are due to injection drug use, and most IDUs have HCV infection. In addi …
Reference Key
ms2005clinicalepidemiology Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sulkowski MS;Thomas DL;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2005
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/15768333
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine research support u.s. gov't N.I.H. Extramural P.H.S. substance abuse hepatitis c / diagnosis hepatitis c / epidemiology* intravenous / epidemiology prevalence hiv infections / complications liver diseases / diagnosis mass screening / methods delivery of health care / methods* intravenous / complications* david l thomas depression / complications depression / therapy pmid:15768333 doi:10.1086/427440 mark s sulkowski hepatitis c / complications hepatitis c / therapy* liver diseases / therapy intravenous / therapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.